发明人张德明,马晓峰,赵玉洁. "一种伊布替尼杂质37的合成方法" [P]. 中国发明专利, 专利号 CN 108854315 A, 授权公告日 2016-09-24.
发明人赵玉洁,胡光,林芳. "Method for the Synthesis of Ibrutinib Impurity 37" [P]. 中国发明专利, 专利号 CN 117479763 A, 授权公告日 2020-07-17.
发明人何建平,张德明,冯建国. "A Process for Preparing High-Purity Ibrutinib Impurity 37" [P]. 中国发明专利, 专利号 CN 112783460 B, 授权公告日 2025-06-17.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 伊布替尼杂质37 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2019, 2129, 1360-1376.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伊布替尼杂质37 as an Impurity". J. Nat. Prod., 2015, 1028, (5), 8385-8410.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Ibrutinib Impurity 37 Using HRMS and NMR". Anal. Chem., 2022, 250, (3), 1148-1152.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 伊布替尼杂质37 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2024, 1905, 7353-7373.